Treatment of AD mice with miR-132 mimics restored memory function and tau metabolism in part. Finally, miR-132 and miR-212 levels correlated with insoluble tau and human cognitive impairment. These findings support a role for miR-132/212 in regulating tau pathology in mice and humans and provide new alternatives for therapeutic development. The gene discussed is MAPT; the disease is Alzheimer disease.